Lofexidine Hydrochloride Tablet, Film Coated
Product Images NDC 66993-345

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lofexidine Hydrochloride (NDC 66993-345). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Prasco Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lofexidine Tablets 1)

Chemical structure of lofexidine hydrochloride, showing its molecular composition including chlorine atoms, a pyrimidine ring, and methyl and oxygen groups.*

FDA Label Image

Figure 1 (Lofexidine Tablets 2)

A line graph showing the proportion of subjects completing a treatment period over study days 1 to 7. The chart compares three groups: Lofexidine 2.16 mg, Lofexidine 2.88 mg, and placebo, illustrating their retention rates during the study.*

FDA Label Image

Figure 2 (Lofexidine Tablets 3)

A line chart showing mean SOWS-Gossop scores over a 7-day study period for lofexidine 2.16 mg, lofexidine 2.88 mg, and placebo groups. The y-axis represents mean scores, and the x-axis represents study days. The chart includes 95% confidence intervals for each group, illustrating symptom score trends and comparative effects over time.*

FDA Label Image

Figure 3 (Lofexidine Tablets 4)

A line graph comparing the proportion of subjects completing the treatment period over study days 1 to 8 for Lofexidine 2.88 mg versus placebo. The vertical axis represents the proportion completing treatment, and the horizontal axis shows study days. The Lofexidine group is depicted with a solid line, while placebo is shown with a dashed line.*

FDA Label Image

Figure 4 (Lofexidine Tablets 5)

A line graph comparing mean SOWS-Gossop scores over five study days for two groups: lofexidine 2.88 mg and placebo. The graph shows mean scores with 95% confidence intervals, with lofexidine scores represented by a solid line and placebo scores by a dashed line, both decreasing over time.*

FDA Label Image

36 Ct (Lofexidine Tablets 6)

Packaging label for Lofexidine Tablets 0.18 mg film-coated tablets by Prasco Laboratories. The label indicates 36 tablets per container, with storage instructions to protect from heat and moisture and keep the bottle tightly closed. It notes each tablet contains 0.18 mg lofexidine (equivalent to 0.2 mg lofexidine hydrochloride) and includes the manufacturer and NDC 66993-345-37.*

FDA Label Image

96 Count (Lofexidine Tablets 7)

Packaging label for Lofexidine Tablets 0.18 mg film-coated tablets by Prasco Laboratories. The label indicates 96 tablets per container, prescription use only, with storage instructions and dosage strength clearly displayed. The label also includes warnings to keep out of reach of children and protect from heat and moisture.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.